Efficacy of exposure versus cognitive therapy in anxiety disorders: systematic review and meta-analysis by Ougrin, Dennis
Efficacy of exposure versus cognitive therapy in
anxiety disorders: systematic review and meta-
analysis
Ougrin
Ougrin BMC Psychiatry 2011, 11:200
http://www.biomedcentral.com/1471-244X/11/200 (20 December 2011)RESEARCH ARTICLE Open Access
Efficacy of exposure versus cognitive therapy in
anxiety disorders: systematic review and
meta-analysis
Dennis Ougrin
Abstract
Background: There is growing evidence of the effectiveness of Cognitive Behavioural Therapy (CBT) for a wide
range of psychological disorders. There is a continued controversy about whether challenging maladaptive
thoughts rather than use of behavioural interventions alone is associated with the greatest efficacy. However little
is known about the relative efficacy of various components of CBT. This review aims to compare the relative
efficacy of Cognitive Therapy (CT) versus Exposure (E) for a range of anxiety disorders using the most clinically
relevant outcome measures and estimating the summary relative efficacy by combining the studies in a meta-
analysis.
Methods: Psych INFO, MEDLINE and EMBASE were searched from the first available year to May 2010. All
randomised controlled studies comparing the efficacy of exposure with cognitive therapy were included. Odds
ratios (OR) or standardised means’ differences (Hedges’ g) for the most clinically relevant primary outcomes were
calculated. Outcomes of the studies were grouped according to specific disorders and were combined in meta-
analyses exploring short-term and long-term outcomes.
Results: 20 Randomised Controlled Trials with (n = 1,308) directly comparing the efficacy of CT and E in anxiety
disorders were included in the meta-analysis. No statistically significant difference in the relative efficacy of CT and
E was revealed in Post Traumatic Stress Disorder (PTSD), in Obsessive Compulsive Disorder (OCD) and in Panic
Disorder (PD). There was a statistically significant difference favouring CT versus E in Social Phobia both in the
short-term (Z = 3.72, p = 0.0002) and the long-term (Z = 3.28, p = 0.001) outcomes.
Conclusions: On the basis of extant literature, there appears to be no evidence of differential efficacy between
cognitive therapy and exposure in PD, PTSD and OCD and strong evidence of superior efficacy of cognitive
therapy in social phobia
Background
There is growing evidence of the effectiveness of Cogni-
tive Behavioural Therapy for a wide range of psychologi-
cal disorders [1].
There is a continued controversy about whether chal-
lenging maladaptive thoughts rather than use of beha-
vioural interventions alone is associated with the
greatest efficacy [2,3]. This issue appears central to any
further enquiry into specific mediators of CBT effect.
Whether or not cognitive or behavioural interventions
are more efficacious is also important from the public
health point of view as behavioural techniques are con-
sidered to be generally simpler and cheaper both in
therapists’ training and in clinical applications [4]. The
argument also has important implications regarding the
theoretical role of cognitive factors in the aetiology and
maintenance of psychiatric conditions.
Exposure and cognitive therapy are two most com-
monly used interventions in the treatment of anxiety
disorders. Exposure has its roots in classical condition-
ing. In exposure patients make contact with the feared
stimuli (either imaginary or in vivo) and this contact is
maintained until the anxiety associated with the contact
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only occur if the patients are prevented from using their
usual escape or avoidance behaviour (extinction). Several
versions of exposure exist. Systematic desensitisation
(SD) is on the gentler part of the spectrum. It is based
on the idea of reciprocal inhibition [5] proposing that
two opposite emotions can not co-exist (e.g. fear and
relaxation are mutually exclusive). In systematic desensi-
tisation relaxation training is followed by gradual
(usually imaginary) exposure to the feared stimuli start-
ing with the least feared stimulus. In contrast, implosion
entails an imaginary exposure to what would be the top
of the hierarchy in SD, and flooding is the same proce-
dure but done in vivo. Exposure has been described as
the most effective way to treat fear [6] Research indi-
cates that the efficacy of exposure is optimal when it is
graduated, repeated and prolonged with practice tasks
clearly specified [6].
For the purposes of this review the definition of cogni-
tive therapy (CT) will be based on the work of David
Clark [7] and could be summarised as follows: CT is the
process of collaboration between the therapist and the
patient leading to the identification of distorted thoughts
(and/or maladaptive beliefs or assumptions) with the
subsequent recognition, monitoring, logical analysis and
empirical hypothesis-testing and finally the re-alignment
of the patients’ cognitions with reality. CT employs a
number of techniques designed to re-align the distorted
cognitions with reality, including thought monitoring
and thought challenging, behavioural experiments, video
feedback, surveys of opinion and the like. No matter
what specific technique is employed, the framework of
cognitive therapy remains constant: to identify the
unhelpful cognition, to examine it in a collaborative
way, to test its validity and then provide the patient
with an opportunity to draw conclusions from their
experience, often leading to revision of the original
cognition.
Cognitive Therapy and Exposure for Anxiety Disorders
Both CT and E alone or in combination have consider-
able efficacy for a range of anxiety disorders [8-11].
However little is known about the relative efficacy of
v a r i o u sc o m p o n e n t so fC B T .T h i sr e v i e wa i m st oc o m -
pare the relative efficacy of CT and E for a range of
anxiety disorders using the most clinically relevant out-
come measures and estimating the summary relative
efficacy by combining the studies in a meta-analysis.
Methods
Selection of studies
A literature search was carried out by using three elec-
tronic databases from the first available year to April
2010 without language limits. Psych INFO, MEDLINE
and EMBASE were searched by using the following sub-
ject headings Cognitive Therapy OR Cognitive Behavior
Therapy OR Behavior Therapy in combination with key
words (* indicates truncation) component* OR process*,
OR mediat* or moderat* or mechanis* OR exposure.
These key words were chosen to capture the studies
analysing therapeutic effects of different components of
CBT. The studies were limited to treatment studies.
Reference lists from the retrieved articles were also
examined to find more relevant studies. In addition
Anxiety, Post Traumatic Stress Disorder and Obsessive
and Compulsive Disorder treatment guidelines were
downloaded from the National Institute of Clinical
Excellence (NICE)’s web site (http://www.nice.org.uk)
and their reference lists were examined for relevant arti-
cles. Finally key investigators at the Oxford Cognitive
Therapy Centre and at the Institute of Psychiatry
(King’s College London) Psychology Department were
contacted in order to find out if there were any relevant
unpublished studies. Authors were contacted if their
data did not provide enough statistical information for
the calculation of effect sizes.
The studies found were then downloaded into End-
Note (version X2) and duplicates were deleted. The
abstracts of the retrieved studies were reviewed and
compared against the inclusion criteria. Where no defi-
nitive decision could be made on the basis of the
abstract alone, the original paper was used.
Full text articles were assessed for eligibility by the
author and by an independent senior researcher. Dis-
agreements were resolved by consensus following a joint
review of the articles and contacting the articles’ authors
if necessary.
Inclusion and Exclusion Criteria
Only RCTs comparing exposure( E )a n dc o g n i t i v et h e r -
apy (CT) in anxiety disorders were included whether
individual or group treatment format was used. The stu-
dies of CT versus E+CT or E versus E+CT were excluded
unless they contained pure CT versus E comparisons.
The studies that contained an arm with pharmacological
treatment were included provided (1) there was a com-
parison of E v CT; (2) there was no differential pharma-
cological treatment between the E and the CT groups.
Studies of CT with or without behavioural experi-
ments and studies of exposure with or without relaxa-
tion training were included. However, studies of
relaxation training without exposure were excluded.
Studies with more than 30% patient attrition were
excluded. As other important study quality characteris-
tics, allocation concealment and blindness were assessed
and reported. Primary outcomes were included if they
were relevant to the efficacy of E or CT for the condi-
tion treated, identified a priory, adequately reported and
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based on self-report. If no primary outcome measure
was identified a priori, an outcome most closely linked
to clinical efficacy was identified and the same quality
considerations were applied as for the primary outcome
measures. The outcomes were also included if they were
possibly blinded but the actual use of blinding was
uncertain. Outcomes that were definitely non-blinded
present a high risk of bias and were excluded. Continu-
ous outcomes had to be assessed by a standardized (pre-
ferably published) rating scale. They had to be assessed
either as a self-report or by an independent (preferably
blinded) rater. Ratings done by therapists were excluded
as they were definitely not blinded and at serious risk of
being biased. This is in accordance with the Cochrane
Handbook [12].
Individual study results
Both raw and transformed data were used for each out-
come. Odds ratios (OR) were calculated for dichotomous
and continuous outcomes and standardized means differ-
ences (Hedges’ g) for continuous outcomes if different
scales were used to report the same outcome. The effect
size index Hedges’ g is similar to Cohen’sd( a n dc a nb e
interpreted similarly), but corrects for small-sample bias
and is therefore more conservative in small samples.
Effect estimates were calculated in such a way that a ben-
eficial effect of CT was always represented by a negative
effect size (for continuous outcomes) or by an odds ratio
smaller than 1 (for dichotomous outcomes).
Pre-test means were assumed to be equal due to the
randomisation.
Combination of study results
R e s u l t sf o rt h es a m et y p eo fo u t c o m e( c h a n g e si ns y m p -
toms) were combined across studies in a meta-analysis.
Results of different outcomes were not combined. For out-
comes where data were available from at least two studies,
traditional meta-analytic summaries were calculated.
Study results were pooled using a fixed effects model.
When a substantial amount of statistical heterogeneity was
found (when I
2 > 50% [12]) and could not be explained, a
random effects model was used. RevMan 5, the pro-
gramme used in Cochrane Collaboration’s meta-analyses
was utilised.
Publication bias
Condition-specific funnel plots were constructed to
examine the publication bias. No publication bias results
in a funnel plot that is symmetrical around the mean
effect size. The Trim and Fill method examines whether
negative or positive trials are over- or underrepresented,
accounting for the sample size. This information can
then be used to recalculate the effect size estimate.
Results
Selection results
The initial search revealed a total of 1,612 articles. Having
applied the exclusion criteria and having removed the
duplicates this was reduced to 61 full text articles assessed
for eligibility. None of the 61 articles were in a language
other than English. There were disagreements about
including 5 articles. Following a consensus meeting 20
RCTs were included in the final quantitative synthesis
(additional file 1, PRISMA flowchart). The main reason
for exclusion was unclear distinction between exposure
and cognitive therapy. In particular the studies that did
not have a clear focus on cognitive change were excluded
from the CT group and the studies that did not have a
clear focus on habituation were excluded from the E con-
dition. The trials were grouped according to the condition
studied: Obsessive Compulsive Disorder (OCD), Post-
Traumatic Stress Disorder (PTSD), Panic Disorder with or
without agoraphobia (PD) and Social Phobia (SP). Asses-
sor blinding was adequate (or a self-reported tool was
used as the main outcome measure) in 11 studies and
uncertain in nine studies. Six countries were represented
in the included studies: Canada, France, the UK, USA and
the Netherlands. Together, the studies enrolled a total of
N = 1,308 patients. Of those 1,044 were allocated to either
CT or E condition and the rest were allocated to a com-
parison treatment or control conditions.
General study characteristics
Studies of Cognitive Therapy versus Exposure in Obsessive
Compulsive Disorder
Five studies have met the criteria for inclusion in this
meta-analysis. Their results were reported in six articles
[13-18] (Table S1, additional file 2). All included studies
reported the pre- and post-treatment values for Yale-
Brown Obsessive Compulsive Scale (Y-BOCS). This is a
semi-structured clinician-administered interview providing
a score (range 0-40) for both obsessions (range 0-20) and
compulsions (range 0-20) along five dimensions: time
spent, interference, distress, resistance, and control
[19,20]. One of the studies [14] contained a condition of E
+ fluvoxamine and CT + fluvoxamine. These two condi-
tions were excluded due to drop out rates exceeding 30%
(36% and 41% respectively); however the pure E and CT
groups were included in the review and the meta-analysis.
The studies comparing Rational Emotive Therapy (RET)
with Exposure [21,22] were excluded as the RET model
lacks theoretical coherence and empirical evidence
afforded by the modern cognitive behaviour models.
Studies of Cognitive Therapy versus Exposure in Post
Traumatic Stress Disorder
Five studies met the criteria for inclusion in this meta-
analysis [23-27] (Table S2, additional file 3). Three of
the included studies reported the pre- and post-
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scale (CAPS) [28]. CAPS has 30 items, assessor-rated,
rating frequency and intensity of the 17 PTSD symp-
toms and 8 associated features of PTSD (built over acts
of commission or omission, survivor guilt, homicidality,
disillusionment with authority, hopelessness, memory
impairment and forgetfulness, sadness and depression
and feeling overwhelmed). Each item is rated 0-4 for
intensity and frequency. One study [26] used an aggre-
gate PTSD severity index calculated by adding the
interviewer’s severity rating of the following PTSD
symptoms: reliving experiences, nightmares, flashbacks,
avoidance of reminders and thoughts of the assault,
impaired leisure activities (e.g., reduced socializing),
sense of detachment, blunted affect, disturbed sleep,
memory and concentration difficulties, hyperalertness,
increased startle response, feelings of guilt, and
increased fearfulness. One study used PTSD Symptom
Scale - Interview (PSS-I) [29] The scale contains 17
items that diagnose PTSD according to Diagnostic and
Statistical Manual of Mental Disorders-III-Revised
(DSM-III-R) criteria and assess the severity of PTSD
symptoms.
Studies of Cognitive Therapy versus Exposure in Panic
Disorder with or without Agoraphobia
Seven studies met the criteria for inclusion in this meta-
analysis [30-35] (Table S3, additional file 4). Six included
studies reported the pre- and post-treatment values for
the proportion of the patients free from panic attacks
based on self-report. One study [33] only gave the raw
number of reported panic attacks; however the propor-
tion of the patients free from panic attack was calcu-
lated on the basis of the data provided.
Studies of Cognitive Therapy versus Exposure in Social
Phobia
Three studies met the inclusion criteria for this meta-ana-
lysis [36-38] (Table S4, additional file 5). Two studies used
a social phobia composite score as the main outcome
measure and one study used Social Phobia and Anxiety
Inventory (SPAI) as the main outcome measure. The SPAI
[39] is a 109-item self-report instrument that has been
widely used to assess the cognitive, somatic and beha-
vioural dimensions of social phobia. One of the studies
used a comparison between Cognitive Therapy and Expo-
sure with Fluoxetine or Exposure with Placebo. The arm
including Fluoxetine treatment was excluded as per inclu-
sion criteria.
Meta-analyses
Meta-analysis of Cognitive Therapy versus Exposure
Efficacy in Obsessive Compulsive Disorder
Short-term outcomes
Five studies reported short-term efficacy (the end of
treatment mean Y-BOCS score) of CT versus E in 290
patients (Table 1). The overall effect is summarised in
Figure 1. There was no statistically significant difference
between the two conditions. Fixed-effects model was
used to estimate the overall effect as there was no
evidence of significant heterogeneity (I
2 = 49%).
Long-term outcomes
Four studies reported long-term efficacy (the mean
Y - B O C Ss c o r ea tt h ep o i n to ft h el o n g e s tr e p o r t e df o l -
low up) of CT versus E in 181 patients (Table 1). The
overall effect is summarised in Figure 2. There was no
statistically significant difference between the two condi-
tions. Random-effects model was used to estimate the
overall effect as there was evidence of significant hetero-
geneity (I
2 = 51%).
Meta-analysis of Cognitive Therapy versus Exposure
Efficacy in Post Traumatic Stress Disorder
Short-term outcomes
Five studies reported short-term efficacy of CT versus E
in 287 patients (Table 2). The overall effect (the end-of-
treatment standardized mean differences, Hedge’sg )i s
summarised in Figure 3. There was no statistically signifi-
cant difference between the two conditions. Fixed-effects
model was used to estimate the overall effect as there
was no evidence of significant heterogeneity (I
2 = 29%).
Long-term outcomes
Four studies reported long-term efficacy reported long-
term efficacy of CT versus E in 226 patients (Table 2).
The overall effect (the standardized means differences,
Hedge’s g at the longest-reported follow up) is sum-
marised in Figure 4. There was no statistically significant
difference between the two conditions. Fixed-effects
model was used to estimate the overall effect as there
was no evidence of significant heterogeneity (I
2 = 0).
Meta-analysis of Cognitive Therapy versus Exposure
Efficacy in Panic Disorder with or without Agoraphobia
Short-term outcomes
Seven studies reported short-term efficacy (the end of
treatment proportion of panic-free patients) of CT ver-
sus E in 274 patients (Table 3). The overall effect is
summarised in Figure 5. There was no statistically sig-
nificant difference between the two conditions. Ran-
dom-effects model was used to estimate the overall
effect as there was evidence of significant heterogeneity
(I
2 = 68%).
Long-term outcomes
Six studies reported long-term efficacy (the end of treat-
ment proportion of panic-free patients) of CT versus E
in 247 patients (Table 3). The overall effect is sum-
marised in Figure 6. There was no statistically significant
difference between the two conditions. Fixed-effects
model was used to estimate the overall effect as there
was no evidence of significant heterogeneity (I
2 = 24%).
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Exposure in Social Phobia
Short-term outcomes
Three studies reported short-term efficacy of CT versus
E in 128 patients (Table 4). The overall effect (the end-
of-treatment standardised means differences, Hedge’sg )
is summarised in Figure 7. There was a statistically sig-
nificant difference favouring CT versus E. Fixed-effects
model was used to estimate the overall effect as there
was no evidence of significant heterogeneity (I
2 = 45%).
Long-term outcomes
Two studies totalling 75 patients reported long-term effi-
cacy (the standardised means differences, Hedge’sg ,a t
the longest-reported follow up) of CT versus E (Table 4).
The overall effect is summarised in Figure 8. There was a
statistically significant difference favouring CT versus E.
Fixed-effects model was used to estimate the overall
effect as there was no evidence of significant heterogene-
ity (I
2 =0 )
Publication bias
Condition-specific funnel plots did not indicate publica-
tion bias. Small number of studies in each comparison,
however, means that the assessment of publication bias
needs to be interpreted with caution.
Other anxiety disorders
There are studies examining relative efficacy of expo-
sure and cognitive therapy in other anxiety disorders:
hypochondriasis [40] and generalised anxiety disorder
(GAD) [41]. More studies are needed before a
summary effect of CT versus E could be estimated in
these conditions.
Discussion
Cognitive Therapy v Exposure in OCD PTSD and PD
This meta-analysis provided no evidence of a statistically
significant difference in efficacy between exposure and
cognitive therapy for the clinically relevant outcome
measures across RCTs studying OCD, PTSD, and panic
disorder with or without agoraphobia.
This does not mean that cognitive changes do not
mediate the treatment response as it is possible that
cognitions could change and mediate treatment through
means other than cognitive therapy. Cognition changes
in the trials of pharmacotherapy have indeed been
demonstrated [42]. Behavioural work could also result
in cognitive changes even in the absence of direct cogni-
tive therapy [43]. There is also growing evidence of the
role cognitive mediation might play in achieving clinical
improvement during exposure therapy [44].
Equally, it is possible that exposure plays an important
role in some cognitive interventions, behavioural experi-
ments in particular.
In addition, it is possible that the different components
of CBT examined in this study may work on different
systems, such that producing change in one system (for
example, the behavioural system) will produce changes in
other systems (such as the cognitive system) [41,45]. If
this was the case then it is not surprising that component
Table 1 Results of the studies of exposure versus cognitive therapy in OCD, Y-BOCS total score
Study Main OM Pre-treatment End of Treatment Longest follow up Longest follow up
CT E CT E (weeks) CT E
Van Balkom 1998 Y-BOCS 25.0(6.6) 24.7 (7.7) 13.5 (9.7) 17.1 (8.4) 26 11.0 (7.5) 11.1 (7.1)
Van Oppen 1995 Y-BOCS 24.1 (5.5) 25.4 (7.0) 13.3 (8.5) 17.3 (8.3) NA NA NA
Cottraux 2001 Y-BOCS 28.6 (5.1) 28.5 (4.9) 12.5 (8.2) 12.1 (7.8) 52 13.6 (8.8) 17.4 (8.5)
McLean 2001 Y-BOCS 21.9 (5.8) 21.8 (4.6) 16.1 (6.7) 13.2 (7.2) 104 17.3 (8.4) 12.8 (7.2)
Whittal 2005 Y-BOCS 23.50 (4.3) 21.66 (5.9) 10.6 (7.1) 10.4 (7.6) 104 10.3 (6.2) 11.2 (8.8)
Note. CT = Cognitive Therapy; E = Exposure; Y-BOCS = Yale-Brown Obsessive Compulsive Scale
Figure 1 Cognitive therapy versus exposure for OCD. Meta-analysis: short-term outcomes Note. SD = Standard Deviation; IV = Inverse
Variance; OCD = Obsessive Compulsive Disorder.
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cognitive therapy in many conditions.
Cognitive Therapy v Exposure in Social Phobia
CT was found to be superior to E in both short term
and long-term outcomes in Social Phobia (effect size
differences from 0.28 to 1.01). A re-evaluation of the
data using a random effects analysis did not change the
overall conclusion. This differential efficacy has not
been shown previously and is potentially of significant
clinical importance. The apparent superiority of CT ver-
sus E in social phobia needs to be accepted cautiously.
First, the studies included in this meta-analysis were
conducted by two research groups that may be espe-
cially proficient in the use of cognitive therapy. Second,
E condition in two of the three studies was individual,
whereas it may be more effective in group setting. Hav-
ing said this, E condition in all three studies demon-
strated significant effect size (0.56- 1.46) and in one
study was based on a manual developed by the investi-
gators and tested in previous studies [38].
It may be that the nature of social phobia makes cog-
nitive interventions especially important in this condi-
tion. The effect of CT may be mediated by an early
change in estimated social cost [38] partly explaining
the long-term CT superiority over E. In addition, there
are studies demonstrating that behavioural experiments
may be more effective in anxiety reduction than expo-
sure alone [46] particularly when an external focus of
attention is used for confronting social anxiety-provok-
ing situations. Exposure in social phobia may be of lim-
ited value without some skills-based behavioural
response. It is also possible that the duration of expo-
sure in social phobic situations is not sufficient for it to
b ee f f e c t i v ea sm a n ys o c i a le n c o u n t e r sh a v eb r i e fd u r a -
tion. Cognitive therapy draws on a range of techniques
to achieve therapeutic change, some of which have
already been demonstrated to be superior to exposure
alone. For instance, the impact of video feedback, ima-
gery work and the negative consequences of self-direc-
ted attention have all been demonstrated experimentally
[47,48]. In summary, CT appears to be more effective
than exposure alone in social phobia; however more stu-
dies from a range of research groups are needed to con-
firm this finding.
Is there a need to challenge thoughts in CBT?
Since there is no evidence of differential efficacy of CT
and E for some conditions, is it therefore necessary to
employ cognitive interventions in the treatment of
Figure 2 Cognitive therapy versus exposure for OCD. Meta-analysis: long-term outcomes Note. SD = Standard Deviation; IV = Inverse
Variance; OCD = Obsessive Compulsive Disorder.
Table 2 Results of the studies of exposure versus cognitive therapy in PTSD, mean PTSD rating scales’ scores
Study Main OM Pre-treatment End of Treatment Longest follow
up
Longest follow up
CT E CT E (weeks) CT E
Terrier 1999 CAPS 76.93 (15.4) 71.76
(19.59)
50.82
(23.99)
48.24
(30.25)
52 52.48
(24.09)
45.16
(28.26)
Marks 1998 (reported in Lovell et al
2001)
CAPS 74.7 (18.1) 61.9 (15.7) 39.5 (23.7) 31.5 (30.7) 26 29.4 (18.7) 14.3 (16.2)
Resick 2008 CAPS 73.87
(21.04)
70.38 18.65 31.32
(37.00)
44.76 31.55 26 31.03
(27.57)
35.90
(27.09)
Foa 1991 PTSD
severity
24.3 (6.1) 25.01 (4.64) 9.89 (4.2) 13.56 (10) 12 12.33 (9.59) 10.44 (8.22)
Foa 1999 PSS-I 29.42 (8.69) 29.48 (9.94) 12.89 (8.96) 11.7 (7.32) 52 12.64
(14.71)
10.69 (8.96)
Note. CT = Cognitive Therapy; E = Exposure; CAPS = Clinician Administered PTSD scale; PSS-I = PTSD Symptom Scale - Interview
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position could be summarised in this way. 1. There is
some evidence that cognitive interventions and beha-
vioural interventions have similar effect sizes for certain
conditions [10] or there is even a superiority of modified
behavioural interventions compared with purely cognitive
interventions [49]. 2. The rapid response argument [50]
centres on the idea that many patients show an improve-
ment early in the course of CBT [51] making the effect of
cognitive interventions an unlikely mediator of this
change (on the assumptions that cognitive interventions
require several weeks to be implemented fully) 3. The
mediation argument proposes that there is no compelling
evidence demonstrating that cognitive change is the
underlying mechanism of improvement in CBT. 4. The
cost-effectiveness argument where behavioural interven-
tions are seen as cheaper to teach and to implement.
This meta-analysis contributed to the discussion on
the first of these points. It would appear that even
within the field of anxiety disorders there is no categori-
cal evidence of equivalence between cognitive and beha-
vioural interventions and it may be that cognitive and
b e h a v i o u r a li n t e r v e n t i o n sm a yb em o r es u i t a b l ef o r
certain conditions. Having said this there was no evi-
dence of a difference in effect size between CT and E in
three out of four anxiety conditions.
The rapid response argument would appear to be the
weakest of the four. There is plenty of evidence docu-
menting cognitive changes early in the cognitive treat-
ment [33,52]. In addition, there is more and more
evidence of cognitive change not being specific to cogni-
tive therapy [42].
The mediation argument is the most complex one as
the criteria for mediation differs depending on the study
design [53,54]. For RCTs the test of mediation is pro-
posed to include these variables: (1) the proposed med-
iator correlates with treatment assignment; (2) the
mediator has either a main or interactive effect on out-
come; and (3) changes in the mediator variable precede
changes in the dependent variable. Very few studies
address all of these criteria. In addition the issue is con-
founded by the rapid response phenomenon. The litera-
ture on cognitive change as a mediator of improvement
is growing, although it remains somewhat inconsistent
[38,42,55]. Future studies are likely to clarify the
mechanisms of change in CBT further.
Figure 3 Cognitive therapy versus exposure for PTSD. Meta-analysis: short-term outcomes Note. SD = Standard Deviation; IV = Inverse
Variance; PTSD = Post Traumatic Stress Disorder.
Figure 4 Cognitive therapy versus exposure for PTSD. Meta-analysis: long-term outcomes Note. SD = Standard Deviation; IV = Inverse
Variance; PTSD = Post Traumatic Stress Disorder.
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died. There is some evidence of a greater cost of teach-
ing a range of cognitive skills as opposed to exposure
alone. The cost of implementation of exposure versus
cognitive therapy is also poorly studied but is likely to
be lower. It is worth mentioning that all but one of the
studies included in this meta-analysis allocated equal
time to both CT and E treatment. The studies of relative
cost-effectiveness of E versus CT are timely.
Limitations
The results of a meta-analysis depend firstly on the results
of the individual studies included. Therefore, their limita-
tions should be mentioned here first. The studies with
very high risk of bias (e.g. with very high drop-out rates)
were excluded from the review. Although only RCTs were
included, some would appear to have had ‘weaker’ designs
than the strongest ones that exist. This was done to
enhance external validity. In half of the studies it was
uncertain whether or not outcome assessment was ade-
quately blinded. Similarly, concealment of allocation was
often uncertain. In addition no standardised quality assess-
ment tools were used to assess the quality of the studies
included. One significant limitation of most studies
included is the lack of an explicitly designated a-priori pri-
mary outcome measure. None-the-less the outcome mea-
sures included in the meta-analysis were either designated
as primary or have been well validated in other studies.
Although great care was taken to include pure cogni-
tive therapy versus pure exposure approach to treatment
it is possible that a certain amount of E and CT were
used across the comparison studies. In addition the
effect of adding CT to E (or E to CR) was not studied in
this meta-analysis. Based on that, a logical and useful
next step in this field of research would be to examine
the additive value of E and CT across different
conditions.
Only the principal clinical efficacy outcomes were
examined in this meta-analysis. On one hand this
allowed for a comprehensive and straightforward com-
parison of two commonly used techniques. On the
o t h e rh a n d ,i tm a yb et h a tc o m p a r i n gt h eo u t c o m e s
other than clinical efficacy (for example depressive
symptomatology, drop out rates or quality of life mea-
sures) could have contributed to a different interpreta-
tion of the results.
The potential impact of researcher allegiance has been
much debated in psychotherapy research [56]. Although
Table 3 Results of the studies of exposure versus cognitive therapy in panic disorder, panic-free patients
Study Main OM Pre-treatment End of Treatment Longest follow up Longest follow up
CT E CT E (weeks) CT E
Arntz 2002 Panic free 0 0 69% 63% 26 75% 71%
Bouchard 1996 Panic free 0 0 64% 79% 26 43% 71%
Marchant 2008 Panic free 0 0 79% 90% 52 59% 82%
Salkovskis 2007 Panic free 0 0 63% 13% NA NA NA
Williams and Falbo 1996 Panic free 0 0 57% 58% 104 50% 80%
Clark 1994 Panic free 0 0 90% 50% 64 85% 47%
Arntz and van den Hout 1995 Panic free 0 0 78% 50% 26 78% 50 %
Note. CT = Cognitive Therapy; E = Exposure
Figure 5 Cognitive therapy versus exposure for panic disorder. Meta-analysis: short-term outcomes Note. SD = Standard Deviation; IV =
Inverse Variance.
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Page 8 of 12it was not the focus of this review, it should be men-
tioned here as a potential limitation. It is plausible to
assume that most studies in this review were carried out
by researchers who have positive allegiances to either
cognitive or behavioural interventions. However, the
high consistency of the efficacy identified in this review
makes bias from researcher allegiance unlikely.
Finally, the small number of studies with small sample
size deserves mentioning as a limitation coupled with
selected demographic characteristics of the subjects (pri-
marily Caucasian adults) and the treatments delivered
mainly by highly trained therapists in the centres of
excellence. These factors reduce the generalisability of
the findings of this meta-analysis and limit the potential
for sensitivity analyses on possible confounding variables
or predictor variables.
Implications for Practice
The findings of this review have several implications for
p r a c t i c e .F i r s t ,t h e yu n d e r l i n et h ev a l u eo fC B Ta sa n
effective treatment in mental health care. Second, the
findings imply that there is no evidence of statistically
significant difference in E versus CT across several but
not all conditions. It has to be noted, however, that the
extent of individual benefit from E versus CT might
vary from patient to patient. Some may respond better
to one of the two interventions and some might do bet-
ter with a combination.
The lack of difference of efficacy between E and CT in
OCD, PTSD and PD is important for clinical reasons.
The British NICE guidelines state that ERP must be
offered as part of CBT for OCD. The guideline develop-
ment group conducted several comparisons, however
only one study was used to compare the efficacy of CT
v ERP [57]. This study showed no significant difference
in the initial analysis of the efficacy of CT v ERP (these
findings were used for the present study); however after
adjustment for medication use a marginally significant
result was reported in favour of ERP (p = 0.049).
Further studies are required to inform the NICE recom-
mended interventions for OCD
The NICE guidelines for PTSD recommend the use of
trauma-focused CBT or EMDR as a first line psychologi-
cal treatment. Equal efficacy of CT versus E reported in
this meta-analysis is in line with this recommendation.
The NICE guidelines on the management of Panic
Disorder also recommend CBT as the first line psycho-
logical treatment with no specific recommendation of
exposure or cognitive therapy as an important ingredi-
ent. The comparisons between cognitive and behavioural
interventions used to inform the guideline development
was based on two studies [30,58] one of which was
excluded from this meta-analysis due to the main out-
come measure not being reported [58].
At present there are no NICE guidelines on the man-
agement of social phobia. Clinicians might like to note
the relative superior efficacy of cognitive therapy over
exposure found in this meta-analysis.
A further implication for practice, the lack of evidence
for a difference of efficacy between E and CT in PD,
Figure 6 Cognitive therapy versus exposure for panic disorder. Meta-analysis: long-term outcomes Note. SD = Standard Deviation; IV =
Inverse Variance.
Table 4 Results of the studies of exposure versus cognitive therapy in social phobia, effect size
Study Effect size End of Treatment Longest follow Longest follow up up (weeks)
CT v E (SE) 95% CI (weeks) CT v E (SE) 95% CI
Clark 2003 Hedge’s g -0.87 (0.33) (-1.52) - (-0.22) 52 NA NA
Clark 2006 Hedge’s g -1.01 (0.33) (-1.65) - (-0.36) 52 -0.85 (0.32) (-1.48) - (-0.22)
Hofmann 2004 Hedge’s g -0.28 (0.26) (-0.79) - 0.23 26 -0.7 (0.34) (-1.37) - (-0.03)
Note CT = Cognitive Therapy; E = Exposure
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Page 9 of 12OCD and PTSD raises the question of differential indica-
tion for behavioural versus cognitive treatment. If E v.
CT is not the main determinant of the effect of CBT,
then what other criteria might be more fruitful in deter-
mining who should receive a particular CBT interven-
tion? Psychotherapy researchers have argued that factors
such as the match between therapist and client and the
client’s motivation for a specific type of therapy should
be recognised more [59]. The use of such “soft” indica-
tions can often be more fruitful than an uncritical ‘pre-
scription’ based on the availability or the services and the
therapists’ allegiance. For policy makers it will be impor-
tant to take into account the findings of this review to
consider the relative need of training in E v. CT.
There are no good studies documenting the economic
implications of teaching and supervising CT v. E and it
may be important to undertake such studies especially
bearing in mind the recent government initiatives pro-
moting wider use of CBT in the UK and elsewhere.
Conclusions
This systematic review and meta-analysis compared the
clinical efficacy of exposure and cognitive therapy in the
treatment of anxiety disorders. On the basis of the
extant literature, there appears to be no evidence of dif-
ferential efficacy between exposure and cognitive
therapy in PD, PTSD and OCD and strong evidence of
superior efficacy of cognitive therapy in social phobia. In
light of the findings of this meta-analysis the necessity
of including ERP in the treatment of OCD appears to be
questionable. Cognitive interventions might have a parti-
cularly important role to play in social phobia. This
finding should be noted when the clinical guidelines for
social phobia are developed.
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